Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Beacon Medical Group

Neither a doctor nor a teaching hospital

Research payments

$300,644

184 payments

Through program year 2025, Beacon Medical Group is reported as receiving $300,644 in research payments, across 184 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $39,069 73
2024 Research $729 3
2023 Research $61,448 17
2022 Research $122,904 41
2021 Research $57,834 22
2020 Research $6,578 3
2019 Research $12,081 25

Breakdown

Who paid Research payments · program years 2019–2025
  1. LivaNova USA, Inc. $277,634 153 payments
  2. GlaxoSmithKline, LLC. $7,547 5 payments
  3. Neurocrine Biosciences, Inc. $6,562 21 payments
  4. Novartis Pharmaceuticals Corporation $4,500 1 payment
  5. Arbor Pharmaceuticals, Inc. $4,050 2 payments
  6. CutisPharma, Inc. $300 1 payment
  7. Sanofi US Services Inc. $50 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression $110,339 32 payments
  2. A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) $79,834 23 payments
  3. The RECOVERsUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes $47,420 21 payments
  4. Recover $39,069 73 payments
  5. A 5-Year Prospective Observational Registry to Assess Adverse Events O $7,547 5 payments
  6. Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia $5,652 20 payments
  7. Prospective Observational Cohort Study on Natural Disease Progression and Burden Across the Entire Alzheimer?S Spectrum (Imap Study) $4,500 1 payment
  8. Vigilant ObservatIon of GlIadeL WAfer ImplaNT (VIGILANT) Registry: A Multicenter, Observational Registry to Collect Information on the Safety and Effectiveness of Gliadel Wafer (Carmustine Implant) Used in Usual Medical Practice $4,350 3 payments
  9. Rekinect Study $910 1 payment
  10. LivaNova UNCOVER $729 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record